Cancer Therapy Opelika AL

Cancer can affect every part of the body. Cancer treatment varies widely and may include anti-cancer drugs, radiation therapy, chemotherapy, surgery, biological therapies, bone marrow transplantations, targeted cancer therapies, and others. See below to learn more and to gain access to oncologists in Opelika, AL who provide cancer therapy.

Brandon Scott Johnson
(334) 528-4411
2000 Pepperell Pkwy
Opelika, AL
Specialty
Hematology / Oncology

Data Provided by:
Wesley Glisson
(334) 705-1070
2000 Pepperell Pkwy
Opelika, AL
Specialty
Radiation Oncology

Data Provided by:
Edith K Graves
(334) 749-3385
121 N 20th St
Opelika, AL
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Uttam Kumar Podder, MD
(334) 864-0084
921 Harvard Pl
Auburn, AL
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Dhaka Med Coll, Dhaka Univ, Bangladesh (704-03 Pr 7/1972)
Graduation Year: 1987

Data Provided by:
Edith Graves
121 N 20th St Ste 6
Opelika, AL
Specialty
Oncologist
Associated Hospitals
Internal Medcn Assoc

Linda Lee Farmer
(334) 528-4411
2000 Pepperell Pkwy
Opelika, AL
Specialty
Hematology / Oncology

Data Provided by:
Wesley Clayton Glisson, MD
(334) 705-1070
2000 Pepperell Pkwy
Opelika, AL
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Med Coll Of Ga Sch Of Med, Augusta Ga 30912
Graduation Year: 1987
Hospital
Hospital: East Alabama Med Ctr, Opelika, Al
Group Practice: East Alabama Cancer Ctr

Data Provided by:
Linda L Farmer, MD
(334) 705-3336
121 N 20th St
Opelika, AL
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
John Blythe
(305) 229-9919
121 N 20th St
Opelika, AL
Associated Hospitals
Internal Medcn Assocs

Brandon Johnson
(304) 623-3461
2000 Pepperell Pkwy
Opelika, AL
Associated Hospitals
East Alabama Medcl Ctr

Data Provided by:

Female Dangers

While breast cancer is the biggest and most publicized cancer threat American
women face, it is not the only female-specific cancer. Cervical, ovarian and uterine
malignancies affect thousands each year. Learn what to look out for so you don’t fall victim.

By Lisa James

May 2006

If someone says the words “female” and “cancer” to you, the first word that probably pops into your head is “breast.” After all, the numbers are hard to ignore: Almost 213,000 American women develop breast malignancies each year…and more than 40,000 die from them.

But a woman overlooks her reproductive tract at her peril; just ask actress Fran Drescher, who graced the cover of last year’s Annual ET Cancer Issue. In her book, Cancer Schmancer (Warner Books), Drescher explains how she saw nine doctors—count ’em, nine—before her uterine cancer was finally discovered and treated, leaving her unable to bear children. “Women need to understand gynecological cancers and the tests that can help detect them,” she writes. “We have to…become educated consumers, network among ourselves, and gain information and insight into getting diagnosed and getting treatment. Someone gimme a podium!”

Taking our lead from “The Nanny,” ET presents what you need to know about three cancers—cervical, ovarian and uterine—that should be on every woman’s radar. (Statistics given are 2006 estimates from the American Cancer Society [ACS].)

Uterine Cancer: A Hormonal Challenge

What it is: Most are endometrial cancers; they arise in the inner lining (endometrium) of the uterus, the part that grows and is shed over the course of a woman’s menstrual cycle. Tumors called sarcomas can develop in the muscle tissue, but account for only 2% to 4% of all uterine cancers.
Number of women affected: 41,200 cases of endometrial cancer (the most common reproductive-tract malignancy) and 7,350 deaths. It is one of the more treatable cancers though, with a five-year survival rate of 84%.

At greatest risk: Roughly 70% of all women affected are between the ages of 45 and 74. Endometrial cancer shares a lot of risk factors with ovarian cancer because excessive estrogen exposure promotes overgrowth of the uterine lining. Taking the drug tamoxifen for breast cancer also increases risk, as does having undergone pelvic radiation therapy. Genetic history is another factor, particularly in families affected by hereditary nonpolyposis colon cancer (HNPCC).

The symptoms: Abnormal bleeding, especially after menopause. Pain and weight loss can be signs of late-stage disease.

The tests: There are no standard screening tests for this kind of cancer. Abnormal bleeding may prompt your doctor to perform an endometrial biopsy, in which a thin needle is passed through the cervical opening to collect cells in the uterine lining.

Vital info: Try your best to drop those extra pounds. Obesity ups the risk of hormonally driven cancers because fat tissue can transform other hormones into estr...

Click here to read the rest of this article from Energy Times